OptimizeRx Corp Earnings Per Share Diluted

• OptimizeRx Corp showed an increase of +124.5% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from OptimizeRx Corp's annual report (Form 10-K), filed with the SEC on March 12, 2026.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2015: $0.00 per share | Q2 2017: $0.04 (loss) per share | Q3 2017: $0.06 (loss) per share | Q1 2018: $0.02 (loss) per share | Q2 2018: $0.02 per share | Q3 2018: $0.02 per share | Q1 2019: $0.00 per share | Q2 2019: $0.03 per share | Q3 2019: $0.11 (loss) per share | Q1 2020: $0.15 (loss) per share | Q2 2020: $0.07 (loss) per share | Q3 2020: $0.02 (loss) per share | Q1 2021: $0.04 (loss) per share | Q2 2021: $0.02 per share | Q3 2021: $0.00 per share | Q1 2022: $0.21 (loss) per share | Q2 2022: $0.21 (loss) per share | Q3 2022: $0.19 (loss) per share | Q1 2023: $0.37 (loss) per share | Q2 2023: $0.24 (loss) per share | Q3 2023: $0.17 (loss) per share | Q1 2024: $0.38 (loss) per share | Q2 2024: $0.22 (loss) per share | Q3 2024: $0.50 (loss) per share | Q1 2025: $0.12 (loss) per share | Q2 2025: $0.08 per share | Q3 2025: $0.04 per share.
• Over the full 9 years of available data (2017 to 2025), OptimizeRx Corp's Earnings Per Share Diluted has grown by 228.6%.
• Historical annual values: Fiscal year 2025: $0.27 per share | Fiscal year 2024: $1.10 (loss) per share | Fiscal year 2023: $1.03 (loss) per share | Fiscal year 2022: $0.64 (loss) per share | Fiscal year 2021: $0.02 per share | Fiscal year 2020: $0.15 (loss) per share | Fiscal year 2019: $0.23 (loss) per share | Fiscal year 2018: $0.02 per share | Fiscal year 2017: $0.21 (loss) per share.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026